Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on EquityReturn on SalesTimes Interest Earned

Exousia Bio (LMMY) Return on Sales (2023 - 2025)

Lamy (LMMY) has disclosed Return on Sales for 3 consecutive years, with 35.89% as the latest value for Q2 2025.

  • Quarterly Return on Sales rose 3729.0% to 35.89% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 35.89% through May 2025, up 3814.0% year-over-year, with the annual reading at 13.71% for FY2025, 1595.0% up from the prior year.
  • Return on Sales hit 35.89% in Q2 2025 for Lamy, up from 17.71% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 35.89% in Q2 2025 to a low of 1.4% in Q2 2024.
  • Historically, Return on Sales has averaged 7.83% across 3 years, with a median of 0.92% in 2023.
  • Biggest five-year swings in Return on Sales: surged 674bps in 2024 and later skyrocketed 3729bps in 2025.
  • Year by year, Return on Sales stood at 0.92% in 2023, then skyrocketed by 731bps to 5.81% in 2024, then soared by 517bps to 35.89% in 2025.
  • Business Quant data shows Return on Sales for LMMY at 35.89% in Q2 2025, 17.71% in Q1 2025, and 5.81% in Q4 2024.